IMP
Process View
positive regulation of peptide hormone secretion
Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of peptide hormone secretion"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.761 | Human | |
| IGF1R | insulin-like growth factor 1 receptor | 0.668 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.662 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.587 | ||
| VAMP3 | vesicle-associated membrane protein 3 (cellubrevin) | 0.494 | ||
| GABBR2 | gamma-aminobutyric acid (GABA) B receptor, 2 | 0.406 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.390 | ||
| HCK | hemopoietic cell kinase | 0.358 | Human | |
| FYN | FYN oncogene related to SRC, FGR, YES | 0.354 | Human | |
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.338 | ||
| FGB | fibrinogen beta chain | 0.333 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.238 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.225 | ||
| INSR | insulin receptor | 0.205 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.187 | ||
| NAPA | N-ethylmaleimide-sensitive factor attachment protein, alpha | 0.168 | ||
| CAPNS1 | calpain, small subunit 1 | 0.149 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.146 | ||
| FGA | fibrinogen alpha chain | 0.141 | ||
| SNAP23 | synaptosomal-associated protein, 23kDa | 0.132 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.124 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.122 | Human | |
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.096 | ||
| CLASP1 | cytoplasmic linker associated protein 1 | 0.094 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.093 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.091 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.075 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.072 | ||
| MAFA | v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) | 0.066 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.065 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.058 | ||
| SNAP25 | synaptosomal-associated protein, 25kDa | 0.054 | ||
| TTR | transthyretin | 0.049 | ||
| PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.048 | ||
| SH2B1 | SH2B adaptor protein 1 | 0.046 | ||
| FGG | fibrinogen gamma chain | 0.046 | ||
| PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.044 | ||
| GOLGA2 | golgin A2 | 0.042 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.035 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.034 | ||
| ADORA2A | adenosine A2a receptor | 0.033 | ||
| ITK | IL2-inducible T-cell kinase | 0.033 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.031 | ||
| EGFR | epidermal growth factor receptor | 0.028 | ||
| CRP | C-reactive protein, pentraxin-related | 0.026 | ||
| SYK | spleen tyrosine kinase | 0.025 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.025 | Human | |
| LCK | lymphocyte-specific protein tyrosine kinase | 0.024 | Human | |
| IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | 0.023 | ||
| CRHR1 | corticotropin releasing hormone receptor 1 | 0.023 | ||
| SLC6A3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 0.022 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.021 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.021 | ||
| GNAQ | guanine nucleotide binding protein (G protein), q polypeptide | 0.019 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.018 | ||
| NSF | N-ethylmaleimide-sensitive factor | 0.017 | ||
| IRF2 | interferon regulatory factor 2 | 0.016 | ||
| NCK1 | NCK adaptor protein 1 | 0.016 | ||
| PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 0.016 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.014 | Human | |
| SPRR2A | small proline-rich protein 2A | 0.014 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.014 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.014 | ||
| IRS1 | insulin receptor substrate 1 | 0.013 | Rat | |
| FYB | FYN binding protein | 0.013 | ||
| GCKR | glucokinase (hexokinase 4) regulator | 0.013 | ||
| CBARA1 | calcium binding atopy-related autoantigen 1 | 0.013 | ||
| TOM1L1 | target of myb1 (chicken)-like 1 | 0.013 | ||
| GET4 | golgi to ER traffic protein 4 homolog (S. cerevisiae) | 0.012 | ||
| ARRB2 | arrestin, beta 2 | 0.012 | ||
| HIC1 | hypermethylated in cancer 1 | 0.012 | ||
| ANGPT2 | angiopoietin 2 | 0.011 | Human | |
| STAT5A | signal transducer and activator of transcription 5A | 0.011 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.011 | ||
| MAPK10 | mitogen-activated protein kinase 10 | 0.011 | ||
| F2 | coagulation factor II (thrombin) | 0.011 | ||
| PDCD6 | programmed cell death 6 | 0.011 | ||
| IPO13 | importin 13 | 0.011 | ||
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 0.010 | ||
| SIRT1 | sirtuin 1 | 0.010 |